Partial protection to respiratory syncytial virus (RSV) elicited in mice by intranasal immunization using live staphylococci with surface-displayed RSV-peptides

By Cano F.   Plotnicky-Gilquin H.   Nguyen T.N.   Liljeqvist S.   Samuelson P.   Bonnefoy J.-Y.   Stahl S.   Robert A.  

Vaccine, Vol. 18, Iss. 24, 2000-06 ,pp. : 2743-2752

Elsevier

Access to resources Recommend Favorite

Plasmid DNA encoding the respiratory syncytial virus G protein protects against RSV-induced airway hyperresponsiveness

By Miller M.   Cho J.Y.   Baek K.J.   Castaneda D.   Nayar J.   Rodriguez M.   Roman M.   Raz E.   Broide D.H.  

Vaccine, Vol. 20, Iss. 23, 2002-07 ,pp. : 3023-3033

Elsevier

Access to resources Recommend Favorite

Intranasal IFN- gene transfer protects BALB/c mice against respiratory syncytial virus infection

By Kumar M.   Behera A.K.   Matsuse H.   Lockey R.F.   Mohapatra S.S.  

Vaccine, Vol. 18, Iss. 5, 1999-10 ,pp. : 558-567

Elsevier

Access to resources Recommend Favorite

The immunogenicity, protective efficacy and safety of BBG2Na, a subunit respiratory syncytial virus (RSV) vaccine candidate, against RSV-B

By Power U.F.   Plotnicky H.   Blaecke A.   Nguyen T.N.  

Vaccine, Vol. 22, Iss. 2, 2003-12 ,pp. : 168-176

Elsevier

Access to resources Recommend Favorite

Stabilization of respiratory syncytial virus (RSV) against thermal inactivation and freeze-thaw cycles for development and control of RSV vaccines and immune globulin

By Gupta C.K.   Leszczynski J.   Gupta R.K.   Siber G.R.  

Vaccine, Vol. 14, Iss. 15, 1996-10 ,pp. : 1417-1420

Elsevier

Access to resources Recommend Favorite